The smoking cessation pill, varenicline, is gaining attention as an effective solution for those struggling with nicotine addiction, particularly among teens and young adults battling the vaping epidemic.Recent clinical trials conducted by Mass General Brigham have revealed that participants using this FDA-approved smoking aid are more than three times as likely to successfully quit vaping compared to those relying solely on behavioral therapy.
